Trial Care International

Trial Care International (TCI) is a specialized Contract Research Organization (CRO) that provides comprehensive clinical trial management services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2006 and headquartered in Exeter, New Hampshire, the company distinguishes itself through deep expertise in imaging-based clinical trials, particularly those involving radiopharmaceuticals and contrast agents. TCI offers a full suite of services including protocol design, project management, clinical monitoring, regulatory submissions, and biostatistics for Phase I through IV studies. The firm has a proven track record of supporting successful FDA approvals, notably serving as the monitoring CRO for the approval of AZEDRA. With a focus on therapeutic areas such as oncology, cardiology, and neurology, TCI leverages a network of experienced professionals to deliver high-quality, cost-efficient clinical development solutions.